In addition to the required divestitures, the settlement stipulates that UnitedHealth must sell an additional eight facilities if regulatory approvals cannot be obtained for associated divestitures without them. A third-party monitor will be appointed to oversee compliance with the terms of the decree, according to the Justice Department's statement. Related: UnitedHealth Says It's Cooperating With DOJ Over Medicare Practices The agreement also includes provisions ensuring that the buyers of the divested facilities receive not only the physical assets but also the necessary staff and contractual relationships to operate independently and competitively in markets where UnitedHealth and Amedisys previously overlapped. Separate from the divestiture conditions, Amedisys will pay a $1.1 million civil penalty to the federal government for submitting false certifications during the pre-merger notification process governed by the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976.